629 related articles for article (PubMed ID: 34843666)
21. Invasive fungal infections among critically ill adult COVID-19 patients: First experiences from the national centre in Hungary.
Szabo BG; Lakatos B; Bobek I; Szabo E; Szlavik J; Vályi-Nagy I
J Mycol Med; 2021 Dec; 31(4):101198. PubMed ID: 34428666
[TBL] [Abstract][Full Text] [Related]
22. Coronavirus Disease 2019-Associated Pulmonary Aspergillosis in Mechanically Ventilated Patients.
Permpalung N; Chiang TP; Massie AB; Zhang SX; Avery RK; Nematollahi S; Ostrander D; Segev DL; Marr KA
Clin Infect Dis; 2022 Jan; 74(1):83-91. PubMed ID: 33693551
[TBL] [Abstract][Full Text] [Related]
23. Risk factors for COVID-19-associated pulmonary aspergillosis: a systematic review and meta-analysis.
Gioia F; Walti LN; Orchanian-Cheff A; Husain S
Lancet Respir Med; 2024 Mar; 12(3):207-216. PubMed ID: 38185135
[TBL] [Abstract][Full Text] [Related]
24. Prevalence and risk factors for delirium in critically ill patients with COVID-19 (COVID-D): a multicentre cohort study.
Pun BT; Badenes R; Heras La Calle G; Orun OM; Chen W; Raman R; Simpson BK; Wilson-Linville S; Hinojal Olmedillo B; Vallejo de la Cueva A; van der Jagt M; Navarro Casado R; Leal Sanz P; Orhun G; Ferrer Gómez C; Núñez Vázquez K; Piñeiro Otero P; Taccone FS; Gallego Curto E; Caricato A; Woien H; Lacave G; O'Neal HR; Peterson SJ; Brummel NE; Girard TD; Ely EW; Pandharipande PP;
Lancet Respir Med; 2021 Mar; 9(3):239-250. PubMed ID: 33428871
[TBL] [Abstract][Full Text] [Related]
25. COVID-19 associated Pulmonary Aspergillosis in Patients Admitted to the Intensive Care Unit: Impact of Antifungal Prophylaxis.
Frost J; Gornicec M; Reisinger AC; Eller P; Hoenigl M; Prattes J
Mycopathologia; 2024 Jan; 189(1):3. PubMed ID: 38217742
[TBL] [Abstract][Full Text] [Related]
26. Invasive pulmonary aspergillosis in critically ill patients with severe COVID-19 pneumonia: Results from the prospective AspCOVID-19 study.
Lahmer T; Kriescher S; Herner A; Rothe K; Spinner CD; Schneider J; Mayer U; Neuenhahn M; Hoffmann D; Geisler F; Heim M; Schneider G; Schmid RM; Huber W; Rasch S
PLoS One; 2021; 16(3):e0238825. PubMed ID: 33730058
[TBL] [Abstract][Full Text] [Related]
27. [Expert consensus on diagnosis and treatment of severe COVID-19 associated pulmonary
;
Zhonghua Jie He He Hu Xi Za Zhi; 2024 Jan; 47(1):10-23. PubMed ID: 38062689
[TBL] [Abstract][Full Text] [Related]
28. Defining COVID-19-associated pulmonary aspergillosis: systematic review and meta-analysis.
Kariyawasam RM; Dingle TC; Kula BE; Vandermeer B; Sligl WI; Schwartz IS
Clin Microbiol Infect; 2022 Jul; 28(7):920-927. PubMed ID: 35150878
[TBL] [Abstract][Full Text] [Related]
29. COVID-19-associated pulmonary aspergillosis (CAPA): Risk factors and development of a predictive score for critically ill COVID-19 patients.
Calderón-Parra J; Mills-Sanchez P; Moreno-Torres V; Tejado-Bravo S; Romero-Sánchez I; Balandin-Moreno B; Calvo-Salvador M; Portero-Azorín F; García-Masedo S; Muñez-Rubio E; Ramos-Martinez A; Fernández-Cruz A;
Mycoses; 2022 May; 65(5):541-550. PubMed ID: 35212030
[TBL] [Abstract][Full Text] [Related]
30. Risk factors and the value of microbiological examinations of COVID-19 associated pulmonary aspergillosis in critically ill patients in intensive care unit: the appropriate microbiological examinations are crucial for the timely diagnosis of CAPA.
Zhou X; Wu X; Chen Z; Cui X; Cai Y; Liu Y; Weng B; Zhan Q; Huang L
Front Cell Infect Microbiol; 2023; 13():1287496. PubMed ID: 38076456
[TBL] [Abstract][Full Text] [Related]
31. Systematic screening for COVID-19 associated invasive aspergillosis in ICU patients by culture and PCR on tracheal aspirate.
van Grootveld R; van Paassen J; de Boer MGJ; Claas ECJ; Kuijper EJ; van der Beek MT;
Mycoses; 2021 Jun; 64(6):641-650. PubMed ID: 33606324
[TBL] [Abstract][Full Text] [Related]
32. Risk Factors Associated With Mortality Among Patients With COVID-19 in Intensive Care Units in Lombardy, Italy.
Grasselli G; Greco M; Zanella A; Albano G; Antonelli M; Bellani G; Bonanomi E; Cabrini L; Carlesso E; Castelli G; Cattaneo S; Cereda D; Colombo S; Coluccello A; Crescini G; Forastieri Molinari A; Foti G; Fumagalli R; Iotti GA; Langer T; Latronico N; Lorini FL; Mojoli F; Natalini G; Pessina CM; Ranieri VM; Rech R; Scudeller L; Rosano A; Storti E; Thompson BT; Tirani M; Villani PG; Pesenti A; Cecconi M;
JAMA Intern Med; 2020 Oct; 180(10):1345-1355. PubMed ID: 32667669
[TBL] [Abstract][Full Text] [Related]
33. COVID-19-associated pulmonary aspergillosis in patients with severe SARS-CoV-2 infection: A single-center observational study from Greece.
Ouranos K; Tsakiri K; Massa E; Dourliou V; Mouratidou C; Soundoulounaki S; Mouloudi E
Ann Thorac Med; 2023; 18(3):116-123. PubMed ID: 37663880
[TBL] [Abstract][Full Text] [Related]
34. Risk Factors for Coronavirus Disease 2019 (COVID-19)-Associated Pulmonary Aspergillosis in Critically Ill Patients: A Nationwide, Multicenter, Retrospective Cohort Study.
Kim SH; Hong JY; Bae S; Lee H; Wi YM; Ko JH; Kim B; Joo EJ; Seok H; Shi HJ; Yoo JR; Hyun M; Kim HA; Jang S; Mun SJ; Kim J; Kim MC; Jung DS; Kim SH; Peck KR
J Korean Med Sci; 2022 May; 37(18):e134. PubMed ID: 35535369
[TBL] [Abstract][Full Text] [Related]
35. COVID-19-associated pulmonary aspergillosis (CAPA) in hematological patients: Could antifungal prophylaxis be necessary? A nationwide study.
Tamayo-Velasco Á; López-Herrero R; Gómez-García LM; Sánchez-de Prada L; Aguilar-Monserrate G; Martín-Fernández M; Bardají-Carrillo M; Álvaro-Meca A; Tamayo E; Resino S; Miramontes-González JP; Peñarrubia-Ponce MJ
J Infect Public Health; 2024 Jun; 17(6):939-946. PubMed ID: 38613930
[TBL] [Abstract][Full Text] [Related]
36. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
37. COVID-19-associated pulmonary aspergillosis (CAPA) in Iranian patients admitted with severe COVID-19 pneumonia.
Erami M; Hashemi SJ; Raiesi O; Fattahi M; Getso MI; Momen-Heravi M; Daie Ghazvini R; Khodavaisy S; Parviz S; Mehri N; Babaei M
Infection; 2023 Feb; 51(1):223-230. PubMed ID: 36107379
[TBL] [Abstract][Full Text] [Related]
38. Significance of Aspergillus spp. isolation in defining cases of COVID-19 Associated Pulmonary Aspergillosis - CAPA.
Cocio TA; Siqueira LPM; Riciluca KCT; Gimenes VMF; de Andrade TS; Benard G; Martínez R; Bollela VR
Braz J Infect Dis; 2023; 27(4):102793. PubMed ID: 37507102
[TBL] [Abstract][Full Text] [Related]
39. Fungal Infections in the ICU during the COVID-19 Pandemic in Mexico.
Roman-Montes CM; Bojorges-Aguilar S; Corral-Herrera EA; Rangel-Cordero A; Díaz-Lomelí P; Cervantes-Sanchez A; Martinez-Guerra BA; Rajme-López S; Tamez-Torres KM; Martínez-Gamboa RA; González-Lara MF; Ponce-de-Leon A; Sifuentes-Osornio J
J Fungi (Basel); 2023 May; 9(5):. PubMed ID: 37233294
[No Abstract] [Full Text] [Related]
40. Risk factors and outcomes of fungal superinfections in patients with severe COVID-19: an observational study from Pisa academic hospital.
Tiseo G; Galfo V; Occhineri S; Forniti A; Caroselli C; Falcone M; Menichetti F
Infez Med; 2022; 31(1):55-61. PubMed ID: 36908395
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
